These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1867125)

  • 21. Clinical and neuropsychological study with oxiracetam versus placebo in patients with mild to moderate dementia.
    Villardita C; Parini J; Grioli S; Quattropani M; Lomeo C; Scapagnini U
    J Neural Transm Suppl; 1987; 24():293-8. PubMed ID: 3479527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The psychotropic effect of the Pyrovalerone (F-1983), placebo, the milieu therapy and mental condition of the patients in forensic psychiatry].
    Söderholm S; Viukari NM; Rimón R
    Nervenarzt; 1976 Feb; 47(2):88-93. PubMed ID: 768789
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychotropic drug use and cognitive decline among older men and women.
    Dealberto MJ; Mcavay GJ; Seeman T; Berkman L
    Int J Geriatr Psychiatry; 1997 May; 12(5):567-74. PubMed ID: 9193967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.
    Szalma I; Kiss A; Kardos L; Horváth G; Nyitrai E; Tordai Z; Csiba L
    Ann Thorac Surg; 2006 Oct; 82(4):1430-5. PubMed ID: 16996947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of piracetam on cognitive performance in patients undergoing bypass surgery.
    Uebelhack R; Vohs K; Zytowski M; Schewe HJ; Koch C; Konertz W
    Pharmacopsychiatry; 2003 May; 36(3):89-93. PubMed ID: 12806565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of piracetam and oxiracetam on the content of high-energy phosphates and morphometry of astrocytes in vitro.
    Gabryel B; Trzeciak HI; Pudełko A; Cieślik P
    Pol J Pharmacol; 1999; 51(6):485-95. PubMed ID: 10817526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A follow-up study on a randomized, single-blind control of King's Brain pills in treatment of memory disorder in elderly people with MCI in a Beijing community].
    Tian JZ; Zhu AH; Zhong J
    Zhongguo Zhong Yao Za Zhi; 2003 Oct; 28(10):987-91. PubMed ID: 15620194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle.
    Bech P
    Acta Psychiatr Scand; 2009 Nov; 120(5):400-9. PubMed ID: 19807722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.
    Villardita C; Grioli S; Lomeo C; Cattaneo C; Parini J
    Neuropsychobiology; 1992; 25(1):24-8. PubMed ID: 1603291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Bureau of Drugs Symposium on the Development of Psychopharmacologic Drugs for the Cognitively and Emotionally Impaired Elderly.
    Psychopharmacol Bull; 1981 Oct; 17(4):57-116. PubMed ID: 7339665
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
    Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
    Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxiracetam in dementia: a double-blind, placebo-controlled study.
    Bottini G; Vallar G; Cappa S; Monza GC; Scarpini E; Baron P; Cheldi A; Scarlato G
    Acta Neurol Scand; 1992 Sep; 86(3):237-41. PubMed ID: 1414239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cognitive function in alcoholics in a double-blind study of piracetam].
    Buranji I; Skocilić Z; Kozarić-Kovacić D
    Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):269-85. PubMed ID: 6927816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, placebo-controlled, clinical, psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life.
    Saletu B; Linzmayer L; Grünberger J; Pietschmann H
    Neuropsychobiology; 1985; 13(1-2):44-52. PubMed ID: 3897895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.